International Journal of Cell Cloning, Vol 10, 333-337, Copyright © 1992 by AlphaMed Press

ORIGINAL ARTICLES

Serum erythropoietin titers in hematological malignancies and related diseases

A Urabe, K Mitani, K Yoshinaga, S Iki, M Yagisawa, Y Ohbayashi and F Takaku
Division of Hematology, Kanto Teishin Hospital, Tokyo, Japan.

Serum erythropoietin (Epo) titers in patients with various hematological malignancies and related diseases were determined by radioimmunoassay. Serum Epo titer was inversely correlated with hemoglobin concentration in iron deficiency anemia, aplastic anemia, myelodysplastic syndromes (MDS), acute leukemia, malignant lymphoma, multiple myeloma and myelofibrosis, but there was no correlation between serum Epo titer and hemoglobin concentration in chronic myelogenous leukemia or polycythemias. Serum Epo titers in aplastic anemia were much higher than those in iron deficiency anemia. Serum Epo titers in MDS, malignant lymphoma and multiple myeloma differed considerably among patients. Serum Epo titers in untreated polycythemia vera were significantly lower than in treated polycythemia vera or secondary polycythemia.

This article has been cited by other articles:

				M. Piron, M. Loo, A. Gothot, F. Tassin, G. Fillet, and Y. Beguin Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia Blood, January 15, 2001; 97(2): 442 - 448. [Abstract] [Full Text] [PDF]

				F. Corazza, Y. Beguin, P. Bergmann, M. Andre, A. Ferster, C. Devalck, P. Fondu, M. Buyse, and E. Sariban Anemia in Children With Cancer Is Associated With Decreased Erythropoietic Activity and Not With Inadequate Erythropoietin Production Blood, September 1, 1998; 92(5): 1793 - 1798. [Abstract] [Full Text] [PDF]